Top Tweets for #poolbegpharma
Poolbeg Pharma CEO on positive CRS trial review and partnering plans @PoolbegPharma https://t.co/09Pb3jABZy #PoolbegPharma #Biotech #ClinicalTrials #CytokineReleaseSyndrome #CRS #MultipleMyeloma
#POLB (@PoolbegPharma) is one to add to the watchlist.
Encouraging early data & a major derisking step, now waiting on interim Phase 2 results for POLB 001. If they get this right, it is potentially a multi-billion-dollar market opportunity.
📅 Join #PoolbegPharma at the Investor Summit on 18 September at 13:50 for:
“The Importance of Partnering to the Pharmaceutical Industry: The POLB 001 Opportunity”
🔹 Jeremy Skillington, PhD, CEO, Poolbeg Pharma
🔹Michiel Bröker, Head Biopharma EMEA, UBS
🔹Chris Grimes-Crompton, Acumentis Global
🔹 Ed Bowsher (Moderator), Freelance Journalist & Investor
Using POLB 001 as a real-world opportunity, the panel will explore what pharma looks for in potential assets and how partnering opportunities are assessed and valued. 🤝
🤝 Register: https://t.co/mbBCPFYoTy
#POLB #Biotech #Pharma

📰 @DiscoverPharma highlights #PoolbegPharma’s TOPICAL trial and the potential of #POLB 001 to address Cytokine Release Syndrome, a key challenge associated with cancer #immunotherapies.
Read the full article here 👇
https://t.co/0nIpyeyVB0
#Oncology #Biotech #Pharma #DiscoverPharma #CRS

🎙️ New Podcast | #PoolbegPharma CEO Jeremy Skillington joins @that_stocks_guy Charles Archer to discuss:
🔹POLB 001 & its differentiated p38 MAPK mechanism
🔹CRS in cancer immunotherapy
🔹TOPICAL trial progress
🔹The investment case
🎧 Listen here: https://t.co/64uu6jzpee
#POLB #Biotech #Oncology #ClinicalTrials

Poolbeg Pharma enters Exclusive Option Agreement for novel Behçet's Disease treatment
with Silk Road Therapeutics Inc
Read More: https://t.co/cvUaY8rXLM
#POLB #RNS #Stocks #PoolbegPharma #RareDiseases #OrphanDiseases #SilkRoadTherapeutics #BehcetsDisease

#POLB @PoolbegPharma Exec Chairman Cathal Friel purchases 830,000 shares at 11.68p
Following the purchase, Cathal holds 37,219,757 shares representing approximately 7.4% of the issued share capital
#polb001 #poolbegpharma #pharma
https://t.co/9MLmnvhuN0

Poolbeg Pharma's Cathal Friel assumes role of Executive Chairman
to reflect ongoing time commitment
Read More: https://t.co/wsAiTppWFK
#POLB #RNS #Stocks #PoolbegPharma #InfectiousDiseases #DrugDevelopment #POLB #AI #Vaccines #Obesity #GLP1 #Influenza #RSV

Poolbeg Pharma's Cathal Friel assumes role of Executive Chairman
to reflect ongoing time commitment
Read More: https://t.co/g5hzdJQ7gK
#POLB #RNS #Stocks #PoolbegPharma #InfectiousDiseases #DrugDevelopment #POLB #AI #Vaccines #Obesity #GLP1 #Influenza #RSV

CytoReason's disease model platform unlocks novel drug targets for treating Influenza
https://t.co/8Y7ZYj9Ljy
#POLB #PoolbegPharma #NovelTreatments #InfectiousDiseases #Influenza #Pharma #BioTech #DrugDevelopment #Therapeutics #Vaccines #Healthcare #CytoReason

The Future of Drug Discovery: Embracing AI for faster, personalised medicine
https://t.co/mdlm0LgD2h
#POLB #PoolbegPharma #NovelTreatments #InfectiousDiseases #Influenza #Pharma #BioTech #DrugDevelopment #AI #Therapeutics #Vaccines #Healthcare #Cancer #POLB001

Poolbeg reports promising results for POLB 001 in cancer immunotherapy-induced CRS
https://t.co/TcXDPMKGy8
#POLB #PoolbegPharma #NovelTreatments #InfectiousDiseases #Influenza #Pharma #BioTech #DrugDevelopment #AI #Therapeutics #Vaccines #OralVaccines #Healthcare

🚀 #PoolbegPharma, #POLB a beacon in biotech, defies the current funding gloom. https://t.co/FEysM10sK6 With today's breakthrough news, POLB 001 shines as more than a molecule - it's hope against cancer's CRS challenge. In vivo success points to not just scientific strides but a market revolution. #BiotechInnovation 🌟

Our #CEO attended last weeks' @_singercm 'Future of Medicine' event
Jeremy discussed our exciting #AI programmes & took part in an engaging panel discussion alongside #healthcare industry colleagues @hVIVO_UK, @Instemsoftware, @Parsortix, @scancellpharma, @Diaceutics
#POLB
🎉 Fantastic News Alert! 🎉 Poolbeg Pharma (AIM: POLB, OTCQB: POLBF) emerges victorious as the opposition to our Immunomodulator I European patent withdraws, paving a smooth path for future innovations. 🌟 No legal hurdles, just harmonious progress. 💼🤝 #PoolbegPharma #InnovationUninterrupted
“The favourable resolution of the opposition filed against our Immunomodulator I European patent is an important outcome for us Poolbeg. We have full confidence in the strength and validity of our patent portfolio" Jeremy Skillington, PhD, CEO
https://t.co/nRzhIgaqPR
#POLB
Excited to have Dr. Paula Maguire, a renowned immunologist with a PhD, as a Scientific Advisor at Poolbeg Pharma! In a recent YouTube video, she shares her reasons for joining our team and highlights the most thrilling aspects of our pipeline. #PoolbegPharma #Immunology #Innovation #POLB001
Meet our Scientific Advisor, Dr Paula Maguire, who joined #POLB earlier this year with a wealth of knowledge and experience following her PhD in #immunology. Paula discusses why she joined the team & what she finds most exciting about our pipeline
https://t.co/EJrJslUbUg
Interview with VP of Regulatory Affairs of Poolbeg Pharma
https://t.co/loX6JfUHKY
#POLB #PoolbegPharma #ClinicalStage #NovelTreatments #InfectiousDiseases #HumanChallengeTrials #Analysis #AI #DrugDiscovery #Flu #CytoReason #Influenza

Poolbeg identifies multiple new drug targets for flu treatment
https://t.co/y5TuRujd5J
#POLB #PoolbegPharma #ClinicalStage #NovelTreatments #InfectiousDiseases #HumanChallengeTrials #Analysis #AI #DrugDiscovery #Flu #CytoReason #Influenza

Poolbeg Pharma oral vaccine programme moves forward
https://t.co/C4Wj8wlJ4h
#POLB #PoolbegPharma #ClinicalStage #NovelTreatments #InfectiousDiseases #HumanChallengeTrials #Analysis #AI #DrugDiscovery #OralVaccineProgramme #EncOVac

Poolbeg Pharma appoints Brendan Buckley as an Independent Non-Executive Director
"We are delighted to have Brendan join the Board of Directors"
https://t.co/Eo8Okmq6j7
#POLB #RNS #PoolbegPharma #ClinicalStage #NovelTreatments #InfectiousDiseases

Revolutionising drug discovery
https://t.co/jpBhd6cA3b
#POLB #PoolbegPharma #ClinicalStage #NovelTreatments #InfectiousDiseases #HumanChallengeTrials #Analysis #POLB001 #AI #AIHealth

Last Seen Hashtags on Sotwe
Most Popular Users

Elon Musk 
@elonmusk
241.7M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
114.5M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.4M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers







